表紙
市場調査レポート

EpiCast Report:アレルギー性鼻炎の疫学予測

EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023

発行 GlobalData 商品コード 298495
出版日 ページ情報 英文 50 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
EpiCast Report:アレルギー性鼻炎の疫学予測 EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023
出版日: 2014年04月30日 ページ情報: 英文 50 Pages
概要

アレルギー性鼻炎は、鼻腔の炎症を特徴とする、慢性の呼吸器疾患です。世界の主要7ヶ国(米国、フランス、ドイツ、イタリア、スペイン、英国、日本)におけるアレルギー性鼻炎の有病者数は、2013年の1億2,327万人から、2023年には1億2,542万人まで増加すると予測されています。

当レポートでは、世界の主要7ヶ国におけるアレルギー性鼻炎について取り上げ、危険因子の概要と世界の動向、疫学予測、疫学レポート、疾患動向の分析を提供して、概略以下の構成でお届けいたします。

第1章 目次

第2章 イントロダクション

第3章 疫学

  • 疾患の背景
  • 危険因子と併存疾患
    • 家族歴は、小児・成人のアレルギー性鼻炎の強い予測因子
    • 環境におけるアレルギー誘発物質への暴露は、アレルギー性鼻炎のリスクを増加
    • 都市部での生活は、アレルギー性鼻炎のリスクを上昇させる
    • 複数の合併症を患う
  • 世界的な動向
    • 米国
    • EU5ヶ国
    • 日本
  • 予測手法
    • 利用した情報源
    • 利用しなかった情報源
    • 予測の前提条件と手法
  • アレルギー性鼻炎の疫学予測
    • 有病者数
    • 有病者数:年齢別
    • 有病者数:性別
    • 有病率:年齢標準化
    • 分布:重症度別
    • 分布:種類別
    • 特定のアレルギー誘発物質に感作
  • 議論
    • 疫学予測に関する考察
    • 分析の限界
    • 分析の強み

第4章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Allergic rhinitis is a chronic respiratory disease characterized by inflammation of the nasal cavity and affects people of all ages. The main symptoms of allergic rhinitis are sneezing, nasal itching, blocked or runny nose and sore throat. Research suggests that a combination of genetic factors such as family history of allergic rhinitis and environmental factors such as exposure to allergens, including smoke, dust, pollen, insects, molds, or animal dander, may increase the risk for developing allergic rhinitis.

According to GlobalData's epidemiological forecast, the total prevalent cases of allergic rhinitis in the 7MM will increase from 123,273,876 total prevalent cases in 2013 to 125,427,387 total prevalent cases in 2023, at an annual growth rate of 0.17% during the forecast period.

In 2023, the US will have the highest number of the total prevalent cases of allergic rhinitis with 39,031,365 total prevalent cases, followed by Japan with 36,602,227 total prevalent cases.

To forecast the total prevalent cases of allergic rhinitis in the 7MM, GlobalData epidemiologists selected only nationally representative studies that provided total prevalence of allergic rhinitis using uniform diagnostic criteria based on self-reported prevalence of allergic rhinitis. The use of studies that provided uniform diagnostic criteria for total prevalence of allergic rhinitis facilitated meaningful comparison of the forecast total prevalent cases of allergic rhinitis across the 7MM. Furthermore, GlobalData epidemiologists provided a comprehensive forecast of the total prevalent cases of allergic rhinitis segmented by severity (mild, moderate, and severe) as well as type (seasonal, perennial, and both).

Scope

  • The Allergic Rhinitis EpiCast Report provide an overview of the risk factors, comorbidities, and the global and historical trends of allergic rhinitis in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast of the total prevalent cases of allergic rhinitis segmented by sex and age (ages =18 years).
  • The allergic rhinitis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

  • Develop business strategies by understanding the trends shaping and driving the global allergic rhinitis market.
  • Quantify patient populations in the global allergic rhinitis market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for allergic rhinitis therapeutics in each of the markets covered.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Related Reports

3. Epidemiology

  • 3.1. Risk Factors and Comorbidities
    • 3.1.1. Family history of allergic rhinitis is a strong predictor for allergic rhinitis in children and adults
    • 3.1.2. Exposure to allergens in the environment increases the risk for allergic rhinitis
    • 3.1.3. Urban living elevates the risk of allergic rhinitis
    • 3.1.4. Comorbidities
  • 3.2. Global and Historical Trends
    • 3.2.1. US
    • 3.2.2. 5EU
    • 3.2.3. Japan
  • 3.3. Forecast Methodology
    • 3.3.1. Sources Used
    • 3.3.2. Sources Not Used
    • 3.3.3. Forecast Assumptions and Methods
  • 3.4. Epidemiological Forecast of Allergic Rhinitis (2013-2023)
    • 3.4.1. Total Prevalent Cases of Allergic Rhinitis
    • 3.4.2. Age-Specific Total Prevalent Cases of Allergic Rhinitis
    • 3.4.3. Sex-Specific Total Prevalent Cases of Allergic Rhinitis
    • 3.4.4. Age-Standardized Total Prevalence of Allergic Rhinitis
    • 3.4.5. Distribution of Total Prevalent Cases of Allergic Rhinitis by Severity
    • 3.4.6. Distribution of Total Prevalent Cases of Allergic Rhinitis by Type
    • 3.4.7. Allergic Rhinitis Total Prevalent Cases Sensitized to Specific Allergens
  • 3.5. Discussion
    • 3.5.1. Epidemiological Forecast Insight
    • 3.5.2. Limitations of the Analysis
    • 3.5.3. Strengths of the Analysis

4. Appendix

  • 4.1. Bibliography
  • 4.2. About the Authors
    • 4.2.1. Epidemiologists
    • 4.2.2. Reviewers
    • 4.2.3. Acting Director of Epidemiology
    • 4.2.4. Global Head of Healthcare
  • 4.3. About GlobalData
  • 4.4. About EpiCast
  • 4.5. Disclaimer

List of Tables

  • Table 1: Classification of Allergic Rhinitis
  • Table 2: Risk Factors and Comorbidities for Allergic Rhinitis
  • Table 3: Prevalence of Most Frequently Occurring Comorbidities in People with Allergic Rhinitis
  • Table 4: Age-Specific Prevalence of Hay Fever from the NHIS Survey in 2011
  • Table 5: Age- and Sex-Standardized Self-Reported Total Prevalence (%) of Allergic Rhinitis, Ages 20-44 Years, 5EU
  • Table 6: Total Prevalence (%) of Allergic Rhinitis in the EU, Ages 6-14 Years
  • Table 7: 7MM, Sources of Data Used for the Total Prevalence and the Segmentations for Allergic Rhinitis
  • Table 8: 7MM, Sources Excluded for the Epidemiological Forecast of Total Prevalent Cases of Allergic Rhinitis
  • Table 9: 7MM, Total Prevalent Cases of Allergic Rhinitis, Both Sexes, Ages ≥18 Years, N, 2013-2023
  • Table 10: 7MM, Age-Specific Total Prevalent Cases of Allergic Rhinitis, Both Sexes, N (Row %), 2013
  • Table 11: 7MM, Sex-Specific Total Prevalent Cases of Allergic Rhinitis, Ages ≥18 Years, N (Row %), 2013
  • Table 12: 7MM, Distribution of Total Prevalent Cases of Allergic Rhinitis by Severity, Both Sexes, N (Row %), 2013
  • Table 13: 7MM, Distribution of Total Prevalent Cases of Allergic Rhinitis by Type, Both Sexes, N (Row %), 2013
  • Table 14: 7MM, Proportion of Allergic Rhinitis Total Prevalent Cases Sensitized to Specific Allergens, Both Sexes, %, 2013

List of Figures

  • Figure 1: 7MM, Total Prevalent Cases of Allergic Rhinitis, Both Sexes, Ages ≥18 Years, N, 2013-2023
  • Figure 2: 7MM, Age-Specific Total Prevalent Cases of Allergic Rhinitis, Both Sexes, N, 2013
  • Figure 3: 7MM, Sex-Specific Total Prevalent Cases of Allergic Rhinitis, Ages ≥18 Years, N, 2013
  • Figure 4: 7MM, Age-Standardized Total Prevalence (%) of Allergic Rhinitis, Ages ≥18 Years, by Sex, 2013
Back to Top